Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 70
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Equine Vet J ; 52(3): 379-383, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31710379

RESUMEN

BACKGROUND: Chondromalacia of the cranial medial femoral condyle (CMFC) is a potential cause of stifle lameness in adult horses. However, there is scant published evidence of either its occurrence or its clinical significance. OBJECTIVES: To document the occurrence of CMFC seen during diagnostic arthroscopy in adult horses with stifle lameness and to investigate its prognostic significance. STUDY DESIGN: Retrospective cohort study. METHODS: The records were reviewed of all horses with unilateral or bilateral lameness localised to the stifle that underwent diagnostic arthroscopy of the cranial medial femorotibial joint at a UK equine hospital. The surgical findings were noted from each. Case outcomes were determined by unstructured telephone discussions with owners. A satisfactory outcome was defined as a horse that was in ridden work without ongoing anti-inflammatory medication. Multivariable logistic regression was used to create a model with an outcome time point at 12-month post-operatively. RESULTS: One hundred and four horses were included in the study. CMFC was found in 79. In 25 CMFC was the only finding, 54 horses had CMFC plus other pathology and 25 had other pathology, but no CMFC. At 12 months, horses with CMFC were 9.9 (95% CI 2.2-45.0, P<0.01) times more likely to have an unsatisfactory outcome than horses without CMFC. MAIN LIMITATIONS: The study relied on retrospective analysis of clinical notes and archived arthroscopy videos. Assessment of outcome was determined by unstructured telephone interview and therefore there is potential for reporting errors to exist. CONCLUSIONS: CMFC is a common arthroscopic finding in horses with stifle lameness and is significantly associated with an increased likelihood of the horse not being in ridden work at long-term follow-up.


Asunto(s)
Enfermedades de los Cartílagos/veterinaria , Enfermedades de los Caballos , Animales , Artroscopía/veterinaria , Fémur , Caballos , Cojera Animal , Estudios Retrospectivos , Rodilla de Cuadrúpedos
2.
J Biol Regul Homeost Agents ; 15(2): 156-62, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11501973

RESUMEN

Murine mononuclear leukocytes express adrenocorticotropin (ACTH) receptors that were recognized by a monospecific antiserum to the ACTH receptor on Y-1 adrenal cells. The antiserum was utilized in an immunofluorescence (IF) assay to characterize the distribution of ACTH receptors on resting murine mononuclear leukocyte populations. Forty-seven percent of spleen cells, 32% of lymph node cells, and 1% of thymocytes constitutively expressed ACTH receptors. Separation of lymphocytes into purified B cell and T cell populations, followed by IF analysis revealed that 47% of B cells and 23% of T cells possessed ACTH receptors. Helper T cells (CD4+ T cells) constituted the majority of ACTH receptor-positive T lymphocytes. Furthermore, 47% of resident peritoneal macrophages, purified by adherence to plastic, expressed ACTH receptors. The T-lymphocyte mitogen, concanavalin A, interferon gamma, and ACTH enhanced ACTH receptor expression. The differential distribution of ACTH receptor-positive cells among specific leukocyte populations explains in part why differential cellular responses are observed and implies important regulatory functions for these receptors in the generation or regulation of immune responses.


Asunto(s)
Leucocitos Mononucleares/metabolismo , Receptores de Corticotropina/metabolismo , Hormona Adrenocorticotrópica/farmacología , Animales , Anticuerpos , Linfocitos B/inmunología , Linfocitos B/metabolismo , Concanavalina A/farmacología , Femenino , Interferón gamma/farmacología , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/inmunología , Tejido Linfoide/citología , Tejido Linfoide/inmunología , Tejido Linfoide/metabolismo , Macrófagos Peritoneales/inmunología , Macrófagos Peritoneales/metabolismo , Ratones , Ratones Endogámicos C57BL , Neuroinmunomodulación , Receptores de Corticotropina/efectos de los fármacos , Receptores de Corticotropina/inmunología , Proteínas Recombinantes , Linfocitos T/inmunología , Linfocitos T/metabolismo
3.
J Neuroimmunol ; 111(1-2): 152-60, 2000 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-11063833

RESUMEN

To analyze the role of interleukin-10 (IL-10) in experimental autoimmune myasthenia gravis (EAMG) pathogenesis, we induced clinical EAMG in C57BL/6 and IL-10 gene-knockout (KO) mice. IL-10 KO mice had a lower incidence and severity of EAMG, with less muscle acetylcholine receptor (AChR) loss. AChR-immunized IL-10 KO mice showed a significantly higher AChR-specific proliferative response, altered cytokine response, lower number of class II-positive cells and B-cells, but a greater CD5(+)CD19(+) population than C57BL/6 mice. The lower clinical incidence in IL-10 KO could be explained not by a reduction of the quantity, but by a possible difference in the pathogenicity of anti-AChR antibodies.


Asunto(s)
Linfocitos B/inmunología , Interleucina-10/genética , Interleucina-10/inmunología , Miastenia Gravis Autoinmune Experimental/genética , Miastenia Gravis Autoinmune Experimental/inmunología , Receptores Colinérgicos/inmunología , Adyuvantes Inmunológicos/genética , Animales , Antígenos CD19/análisis , Autoanticuerpos/sangre , Linfocitos B/química , Linfocitos B/citología , Proteínas Sanguíneas/inmunología , Antígenos CD5/análisis , División Celular/inmunología , Línea Celular , Citotoxinas/inmunología , Epítopos/inmunología , Antígenos de Histocompatibilidad Clase II/biosíntesis , Antígenos de Histocompatibilidad Clase II/inmunología , Inmunización , Epítopos Inmunodominantes/inmunología , Técnicas In Vitro , Interferón gamma/biosíntesis , Interferón gamma/inmunología , Interleucina-6/biosíntesis , Interleucina-6/inmunología , Recuento de Linfocitos , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Músculo Esquelético/química , Músculo Esquelético/inmunología , Receptores Colinérgicos/genética , Factor de Necrosis Tumoral alfa/biosíntesis , Factor de Necrosis Tumoral alfa/inmunología
4.
Cell Mol Neurobiol ; 20(4): 419-31, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10901264

RESUMEN

1. Elevated proinflammatory cytokines within the central nervous system (CNS) of individuals infected with human immunodeficiency virus (HIV) may contribute to altered CNS processes prior to the onset of AIDS. Most studies of HIV-induced alterations in cytokine expression within the CNS have focused on interleukin (IL)-1 and tumor necrosis factor (TNF). 2. We used a ribonuclease protection assay (RPA) to elucidate further the pattern of cytokine mRNA expression in the rat CNS in response to HIV envelope glycoprotein 160 (gp160). Male Sprague-Dawley rats were surgically implanted with a guide cannula directed into a lateral cerebral ventricle. HIV gp160 was injected intracerebroventricularly and rats were sacrificed immediately (time = 0) or at 1, 2, or 4 hr postinjection. Discrete brain regions were dissected, and peripheral glands removed. All tissues were frozen in liquid nitrogen until RNA extraction and assay. 3. IL-1beta IL-1alpha, TNF-alpha, and TNFbeta mRNAs were constitutively expressed in brain tissues. Central administration of gp160 dramatically increased mRNA expression for IL-1beta and TNFalpha in the hypothalamus, hippocampus, brainstem, and cerebellum. Furthermore, although mRNA expression for IL-5, IL-6, and IL-10 was never detected under basal conditions, these mRNAs were increased in brain tissue after administration of gp160. Peak expression in each brain region was detected 2 hr after administration. Multiple cytokine mRNAs were detected in peripheral tissues, but their expression was not altered by central administration of gp160. 4. Our results indicate that gp160 induces mRNA expression in brain for cytokines other than IL-1 and TNF. Screening for multiple cytokine mRNA in this manner provides extensive information concerning the particular cytokines that may be involved in HIV-induced pathologies and alterations in CNS processes.


Asunto(s)
Complejo SIDA Demencia/metabolismo , Sistema Nervioso Central/virología , Citocinas/genética , Proteínas gp160 de Envoltorio del VIH/metabolismo , VIH/metabolismo , Complejo SIDA Demencia/fisiopatología , Complejo SIDA Demencia/virología , Glándulas Suprarrenales/metabolismo , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Sistema Nervioso Central/metabolismo , Sistema Nervioso Central/fisiopatología , Citocinas/efectos de los fármacos , Proteínas gp160 de Envoltorio del VIH/farmacología , Interleucina-1/genética , Linfotoxina-alfa/genética , Masculino , Ensayos de Protección de Nucleasas , Hipófisis/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Bazo/metabolismo , Factor de Necrosis Tumoral alfa/genética
5.
Anesthesiology ; 92(6): 1677-84, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10839919

RESUMEN

BACKGROUND: The transcription factor NF-kappaB plays a pivotal role in gene expression of inflammatory mediators such as cytokines or adhesion molecules. NF-kappaB-mediated transcriptional activation of these genes is inhibited by nitric oxide (NO) in a variety of cells, including monocytes. Morphine mediates NO release in a naloxone antagonizable manner in monocytes and neutrophils. METHODS: The influence of morphine on NF-kappaB activation was investigated in a whole-blood flow cytometric assay. A specific antibody against the p65 subunit of NF-kappaB was used and detected by fluoresceine-isothiocyanate-labeled anti-immunoglobulin G. Nuclei were stained with propidium iodide. Leukocyte subpopulations were evaluated by gating on neutrophils and monocytes. The median fluorescence channel was determined. Different morphine concentrations (50 nm, 50 microm, 1 mm) and incubation intervals (10-150 min) were used. RESULTS: Morphine inhibits lipopolysaccharide-induced NF-kappaB nuclear binding in human blood neutrophils and monocytes in a time-, concentration-, and naloxone-sensitive-dependent manner. Similar effects were achieved with the NO donor S-nitroso-N-acetyl-pencillamine and the antioxidant N-acetyl-cysteine. The NO synthase inhibitors Nomega-nitro-l-arginine-methyl-esther and Nomega-nitro-l-arginine completely abolished the morphine-induced attenuation of NF-kappaB nuclear binding, demonstrating that the inhibitory action is mediated by NO release. CONCLUSION: Morphine causes immunosuppression, at least in part, via the NO-stimulated depression of NF-kappaB nuclear binding.


Asunto(s)
Analgésicos Opioides/farmacología , Monocitos/metabolismo , Morfina/farmacología , FN-kappa B/metabolismo , Neutrófilos/metabolismo , Óxido Nítrico/fisiología , Acetilcisteína/farmacología , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Inhibidores Enzimáticos/farmacología , Citometría de Flujo , Humanos , Técnicas In Vitro , Lipopolisacáridos , Masculino , Monocitos/efectos de los fármacos , FN-kappa B/efectos de los fármacos , NG-Nitroarginina Metil Éster/farmacología , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Neutrófilos/efectos de los fármacos , Óxido Nítrico Sintasa/antagonistas & inhibidores , Unión Proteica , Receptores Opioides mu/efectos de los fármacos , Receptores Opioides mu/metabolismo
6.
Virology ; 267(2): 247-51, 2000 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-10662620

RESUMEN

Human herpesvirus 8 (HHV-8) has been causally linked to Kaposi's sarcoma (KS). There is significant homology between some HHV-8 genes and cellular genes including D-type cyclin (vCYC), G protein coupled receptor (vGCR), macrophage inflammatory proteins (vMIP-I, vMIP-II), bcl-2 (vBCL2), interferon regulatory factor-1 (vIRF1), interleukin-6 (vIL6), and complement-binding protein (vCBP). In this study, we analyzed expression of these viral homologs and HIV-1 Tat by reverse-transcriptase polymerase chain reaction (RT-PCR) coupled with Southern blot hybridization in AIDS-KS (AKS) tissue, classic KS tissue(CKS), and peripheral blood mononuclear cells, and phorbol ester (TPA)-treated and untreated HHV-8 positive lymphoma cells (BCBL1). While vCYC (AKS 6 of 6; CKS 3 of 3), vMIP-I (AKS 5 of 6, CKS 3 of 3), vBCL2 (AKS 6 of 6; CKS 3 of 3), and vIRF1 (AKS 5 of 6, CKS 3 of 3) transcripts were detected in both AKS and CKS, vGCR and HIV-1 Tat were expressed only in AKS samples (vGCR: AKS 3 of 6, CKS 0 of 3; Tat: AKS 4 of 6, CKS 0 of 3). vMIPII, vCBP, and vIL6 expression were not detected in any KS samples. Since vGCR expression is limited to AKS, it is possible that vGCR is activated by HIV-1 Tat. These results suggest that HIV-1 Tat may contribute to AKS pathogenesis through the tumorigenic and angiogenic effects of vGCR.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Herpesvirus Humano 8/genética , Receptores de Superficie Celular/genética , Sarcoma de Kaposi/genética , Ciclina D , Ciclinas/genética , Regulación Viral de la Expresión Génica , Productos del Gen tat/genética , Productos del Gen tat/fisiología , VIH-1/genética , VIH-1/fisiología , Humanos , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/virología , Oncogenes/genética , ARN/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sarcoma de Kaposi/complicaciones , Sarcoma de Kaposi/virología , Acetato de Tetradecanoilforbol/farmacología , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/metabolismo , Células Tumorales Cultivadas/virología , Proteínas Virales/genética , Productos del Gen tat del Virus de la Inmunodeficiencia Humana
7.
Acta Biol Hung ; 50(1-3): 247-56, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10574444

RESUMEN

We studied the effects of recombinant human interleukin-10 (IL-10) on invertebrate immunocytes and microglia. The present report demonstrates that the spontaneous activation of invertebrate immunocytes can be specifically inhibited by recombinant human IL-10. Induced immunocyte activation by fMLP can also be significantly diminished by IL-10. This inhibition becomes apparent over hours and causes ameboid cells to become round and nonmobile. Furthermore, Mytilus edulis pedal ganglia maintained in culture, over the course of 24 hours, emit microglia. IL-10 significantly reduces this microglial egress, an action that can be diminished by concomitant exposure of the excised ganglia to an antibody specific to IL-10 as well as IL-10. The anti-IL-10 alone is without effect. Active-ameboid microglia that egress become round and inactive following IL-10 exposure, an action prevented by anti-IL-10. Lastly, a substance immunoreactively similar to human IL-10 can be detected in pedal ganglia homogenates. Taken together, and since the immunocytes and microglia are responding to IL-10, it implies that an IL-10-like substance could be present in invertebrates. In conclusion, the study demonstrates that both invertebrate immunocytes and microglia respond to IL-10, suggesting an early evolution of this generally inhibitory cytokine.


Asunto(s)
Ganglios/efectos de los fármacos , Interleucina-10/farmacología , Microglía/efectos de los fármacos , Animales , Bivalvos , Humanos , Microglía/citología , Proteínas Recombinantes/farmacología
8.
J Neuroimmunol ; 100(1-2): 140-8, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10695724

RESUMEN

Certain functional interactions between the nervous, endocrine, and immune systems are mediated by cytokines. The pro-inflammatory cytokines, interleukin-1 (IL-1) and tumor necrosis factor (TNF) were among the first to be recognized in this regard. A modulator of these cytokines, IL-10, has been shown to have a wide range of activities in the immune system; in this review, we describe its production and actions in the hypothalamic-pituitary-adrenal (HPA) axis. IL-10 is produced in pituitary, hypothalamic, and neural tissues in addition to lymphocytes. IL-10 enhances corticotropin releasing factor (CRF) and corticotropin (ACTH) production in hypothalamic and pituitary tissues, respectively. Further downstream in the HPA axis endogenous IL-10 has the potential to contribute to regulation of glucocorticosteroid production both tonically and following stressors. Our studies and those of others reviewed here indicate that IL-10 may be an important endogenous regulator in HPA axis activity and in CNS pathologies such as multiple sclerosis. Thus, in addition to its more widely recognized role in immunity, IL-10's neuroendocrine activities described here point to its role as an important regulator in communication between the immune and neuroendocrine systems.


Asunto(s)
Encéfalo/inmunología , Sistema Hipotálamo-Hipofisario/inmunología , Interleucina-10/inmunología , Interleucina-10/metabolismo , Sistema Hipófiso-Suprarrenal/inmunología , Hormona Adrenocorticotrópica/farmacología , Animales , Secuencia de Bases , Encéfalo/metabolismo , Células Cultivadas , Relación Dosis-Respuesta a Droga , Humanos , Sistema Hipotálamo-Hipofisario/metabolismo , Interferón gamma/metabolismo , Interleucina-10/farmacología , Ratones , Modelos Biológicos , Datos de Secuencia Molecular , FN-kappa B/metabolismo , Sistema Hipófiso-Suprarrenal/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Bazo/metabolismo , Temperatura , Distribución Tisular
9.
Neurosci Lett ; 256(3): 167-70, 1998 Nov 13.
Artículo en Inglés | MEDLINE | ID: mdl-9855366

RESUMEN

Following treatment with interleukin-10 (IL-10), basal corticotrophin releasing factor (CRF) levels from rat hypothalamic median eminence (ME) were found to be increased. Our data show: (1) the specificity of stimulation of CRF through the use of recombinant IL-10 and its blockage by monoclonal anti-IL-10 antibody; (2) the requirement of NO in this process through the use of N(omega)-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor; (3) the blockage of IL-10 stimulated NO production by anti-IL-10; and, (4) the presence of IL-10 transcripts in hypothalamic poly A+ mRNA. These results provide the first evidence of IL-10 acting in the ME to influence CRF levels and further support our earlier findings of a potential for IL-10 in the hypothalamic-pituitary axis.


Asunto(s)
Hormona Liberadora de Corticotropina/metabolismo , Interleucina-10/farmacología , Eminencia Media/metabolismo , Óxido Nítrico/biosíntesis , Animales , Anticuerpos Monoclonales/farmacología , Southern Blotting , Relación Dosis-Respuesta a Droga , Humanos , Interleucina-10/genética , Interleucina-10/inmunología , Leucocitos/química , Masculino , Eminencia Media/efectos de los fármacos , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo I , Hipófisis/química , ARN Mensajero/análisis , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Organismos Libres de Patógenos Específicos
10.
J Clin Endocrinol Metab ; 83(12): 4373-81, 1998 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9851780

RESUMEN

Disruption of the linkage among the immune, nervous, and endocrine systems may contribute to the pathology and symptoms of acquired immunodeficiency syndrome (AIDS). We investigated the role of human immunodeficiency virus (HIV) in altering these linkages via induction of corticotropin (ACTH) by lymphocytes. Cultured T lymphocytes (H9 cell line) were infected with HIV-1, after which ACTH production was measured and characterized at various time intervals by immunofluorescence and Western blotting. We report a coordinate expression of ACTH and p24 HIV core protein in H9 cells. Also, the kinetics of HIV-induced ACTH production by H9 T lymphoma cells are demonstrated using three different strains of HIV as well as UV-inactivated HIV. ACTH production corresponded with the appearance of p24 antigen and was maximal 35 days after infection. UV-inactivated HIV and the viral envelope protein, gp120, were also able to induce ACTH production in these cells, indicating that viral replication was not required for the ACTH induction. The HIV-induced ACTH was synthesized de novo and had the size and biological activity of pituitary ACTH. Inhibition of ACTH in HIV-infected lymphocyte cultures by anti-ACTH antiserum enhanced viral p24 expression. The significance of lymphocyte ACTH in AIDS is not clear, but these results suggest that it may restrict HIV replication and possibly infection.


Asunto(s)
Hormona Adrenocorticotrópica/metabolismo , VIH/fisiología , Linfocitos/metabolismo , Linfocitos/virología , Hormona Adrenocorticotrópica/biosíntesis , Hormona Adrenocorticotrópica/fisiología , Línea Celular , VIH/crecimiento & desarrollo , Proteína gp120 de Envoltorio del VIH/farmacología , Humanos , Cinética , Replicación Viral/fisiología
11.
Int J Cardiol ; 64 Suppl 1: S43-51, 1998 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-9687092

RESUMEN

We demonstrate the presence of both delta and mu opioid receptors on the endothelium of human saphenous vein and internal thoracic artery. Displacement analysis revealed that a variety of opioid peptides were found to be ineffective in displacing specifically bound 3H dihydromorphine and only delta2 ligands were effective in regard to 3H Ala2-met5 enkephalinamide (DAMA), indicating the presence of mu3 and delta2 opioid receptor sites, respectively. Confirming the presence of both mu and delta sites we demonstrated positive immunostaining with anti-delta and anti-mu receptor antibodies. Exposure of these vessels to DAMA significantly enhances granulocyte adherence (P<0.01) even in vessels 5 min later exposed to 10(-6) M morphine. Unlike morphine, DAMA did not stimulate nitric oxide from either blood vessel and human granulocytes. Additionally, DAMA preadministered before morphine exposure to the endothelium or granulocytes, inhibited the morphine-stimulated release of NO in a dose-dependent manner. The data indicate that opioid peptides and opiate alkaloids regulate endothelial function in an antagonistic manner thereby influencing the microvascular environment.


Asunto(s)
Endotelio Vascular/fisiología , Morfina/farmacología , Óxido Nítrico/metabolismo , Receptores Opioides delta/metabolismo , Adhesión Celular , Endotelio Vascular/efectos de los fármacos , Encefalina Metionina/fisiología , Humanos , Técnicas In Vitro , Vena Safena , Arterias Torácicas
12.
J Neuroimmunol ; 83(1-2): 162-7, 1998 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-9610685

RESUMEN

Some of the effects that high-dose anabolic steroid abuse have and could have on the interactions between the immune and neuroendocrine systems are reviewed. Considering the past demonstrations on the actions of normal steroids on endocrine and immune responses, it is apparent that pharmacologically high doses of both normal and derivatized androgens (anabolic steroids) could have a significant effect. Indeed, some of the pathologies attributed to anabolic steroid abuse point to disturbances in the intimate connection between neuroendocrine and immune function and interaction. We attempt to review both the direct and indirect effects of this abuse, not only on this interaction but also on certain immune functions in particular.


Asunto(s)
Anabolizantes/efectos adversos , Anabolizantes/inmunología , Neuroinmunomodulación/efectos de los fármacos , Sistemas Neurosecretores/efectos de los fármacos , Trastornos Relacionados con Sustancias/inmunología , Humanos
13.
Laryngoscope ; 108(5): 735-40, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9591556

RESUMEN

Recurrent respiratory papillomatosis (RRP), usually confined to the nasopharynx, trachea, and larynx, occasionally can progress to extensive bronchopulmonary disease. Most cases of bronchopulmonary and laryngeal papillomatosis are cytologically benign and do not undergo malignant transformation; however, squamous cell carcinoma (SCC) can arise in RRP in the absence of known risk factors such as radiation and smoking. In this study, the authors investigated molecular genetic alterations occurring in a case of metastasizing SCC that arose in long-standing bronchopulmonary papillomatosis. Genomic DNA from tracheal papillomata, tracheobronchial papillomata, SCC of the lung, and a lymph node metastasis was extracted. The physical state of the human papillomavirus type 11 (HPV-11) DNA was investigated by two-dimensional gel electrophoresis. Molecular genetic alterations of the host genome were studied by direct sequencing of polymerase chain reaction-amplified gene fragments and restriction fragment length polymorphism (RFLP) analysis. Episomal and integrated forms of HPV-11 sequences were detected in histologically benign tumors, but only the integrated form of the viral DNA could be found in malignant tissue samples. Molecular genetic studies revealed that an allelic loss of the interferon-beta gene (IFNbeta-1) and an endogenous type of mutation of the p53 antioncogene were found only in the malignant lesions. Mutations were not observed in the ras, neu, or multiple tumor suppressor (MTS1/p16) genes in any specimens. The authors' data indicated that the p53 genetic mutation was associated with integration of HPV-11 in histologically malignant lesions. This association may promote a progressive genetic instability that can lead to the development and clonal expansion of malignant lesions in RRP.


Asunto(s)
Carcinoma de Células Escamosas/patología , Transformación Celular Neoplásica , ADN Viral/análisis , Genes p53/genética , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/patología , Mutación , Papiloma/genética , Papiloma/patología , Papillomaviridae/genética , Adulto , Neoplasias de los Bronquios/genética , Neoplasias de los Bronquios/patología , Genes p16/genética , Humanos , Neoplasias Laríngeas/genética , Neoplasias Laríngeas/patología , Metástasis Linfática , Masculino , Metástasis de la Neoplasia , Recurrencia Local de Neoplasia , Infecciones por Papillomavirus/genética , Infecciones por Papillomavirus/patología , Polimorfismo de Longitud del Fragmento de Restricción , Neoplasias del Sistema Respiratorio/genética , Neoplasias del Sistema Respiratorio/patología , Infecciones Tumorales por Virus/genética , Infecciones Tumorales por Virus/patología
14.
Gen Pharmacol ; 29(1): 73-7, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9195196

RESUMEN

1. The effects of interleukin-2 (rhIL-2) and interleukin-4 (rhIL-4) were investigated on gamma-aminobutyric acid (GABA)-induced inward currents on isolated, identified neurons of Lymnaea stagnalis L. (Mollusca, Gastropoda) by using a concentration clamp technique. 2. It was shown that the interleukins modified the GABA-induced inward current in an opposite direction: rhIL-2 (2-100 U/ml) decreased the peak value of IGABA in a dose-dependent manner, whereas rhIL-4 (0.2-100 U/ml), on the contrary, potentiated it. Both types of modulation were partially or fully reversible. 3. The reversal potential of IGABA was not shifted by these cytokines. 4. The time-to-peak value and inactivation time constant of the gamma-aminobutyric acid (GABA)-induced current was decreased by rhIL-4. The modulatory effect of rhIL-4 was eliminated after conjugation of this cytokine with its antibody. 5. It appears that cytokines could play a role in regulating the neural excitability through GABA-erg mechanisms.


Asunto(s)
Lymnaea/fisiología , Animales , Interleucina-2/farmacología , Interleucina-4/farmacología , Potenciales de la Membrana/efectos de los fármacos , Neuronas/efectos de los fármacos , Neuronas/fisiología , Técnicas de Placa-Clamp , Ácido gamma-Aminobutírico/farmacología
15.
J Cardiovasc Pharmacol ; 30(1): 90-5, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9268226

RESUMEN

Interleukin-10 (IL-10) is described as a cytokine that exerts immune downregulating actions. In this regard, our study indicates that IL-10 activity on human saphenous veins is coupled to nitric oxide (NO) release. We demonstrated this phenomenon by using in vitro real-time amperometric measurement of NO levels in explanted human saphenous veins after IL-10 exposure. IL-10-induced NO release can inhibit the adherence of monocytes (75.7 +/- 15 cells/600 microm2 of endothelial surface) and granulocytes (65 +/- 18 cells/600 microm2 of endothelial surface) from control values (250-300 cells/600 microm2 of endothelial surface; p < 0.005). This inhibition is directly sensitive to NO synthase inhibition. The specificity of the IL-10 effects is shown by its sensitivity to antibody. In vivo measurement of IL-10 levels during and after cardiopulmonary bypass surgery indicated that they are higher at 6 h after skin closure (1,400 pg/ml) compared with levels found during surgery (300 pg/ml). We surmise that the postsurgical increase of IL-10 levels may be an immunoregulatory attempt to downregulate the diffuse inflammation that has been shown to be associated with cardiopulmonary bypass surgery.


Asunto(s)
Endotelio Vascular/fisiología , Granulocitos/fisiología , Interleucina-10/inmunología , Monocitos/fisiología , Óxido Nítrico/biosíntesis , Vena Safena/fisiología , Anciano , Anticuerpos/inmunología , Adhesión Celular/inmunología , Regulación hacia Abajo , Endotelio Vascular/inmunología , Granulocitos/inmunología , Humanos , Técnicas In Vitro , Interleucina-10/sangre , Persona de Mediana Edad , Monocitos/inmunología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Vena Safena/inmunología , Vena Safena/metabolismo
16.
Proc Soc Exp Biol Med ; 215(1): 66-73, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9142139

RESUMEN

This is the first study documenting the induction of gamma-interferon (IFN-gamma) in human embryonic fibroblasts during human cytomegalovirus (HCMV) replication. Infection of cells with HCMV resulted in the consistent production of IFN-gamma RNA, as determined by RT-PCR and Northern blot analysis. Western blot analysis of cell lysates and immunoprecipitates from the cultural fluids of infected cells demonstrated the presence of IFN-gamma at the protein level. Induction of IFN-gamma required infectious HCMV, since high-dose ultraviolet inactivation of the virus stock eliminated IFN-gamma production. Further, IFN-gamma induction appears to be a late event in the virus replication cycle, since inhibition of HCMV DNA synthesis (e.g., phosphonoacetic acid) blocked the increase in IFN-gamma. Soluble factor(s) released from HCMV-infected cells apparently did not contribute to the induction of IFN-gamma, since virus stocks from which virus had been removed by sedimentation did not induce production of IFN-gamma. The appearance of IFN-gamma at late stages of HCMV infection and its elimination in the presence of an inhibitor (Actinomycin D) of RNA synthesis indicate a true transcriptional induction of this lymphokine at the RNA and protein levels. The significance of IFN-gamma production with regard to the replication and pathogenesis of HCMV in vitro and in vivo will require further investigation.


Asunto(s)
Citomegalovirus/fisiología , Interferón gamma/biosíntesis , Replicación Viral , Northern Blotting , Western Blotting , Línea Celular , Replicación del ADN/efectos de los fármacos , ADN Viral/genética , Dactinomicina/farmacología , Fibroblastos , Regulación de la Expresión Génica , Humanos , Interferón gamma/genética , Interferón gamma/farmacología , Cinética , Inhibidores de la Síntesis del Ácido Nucleico/farmacología , Ácido Fosfonoacético/farmacología , Reacción en Cadena de la Polimerasa , ARN/genética , ARN/metabolismo , Proteínas Recombinantes , Rayos Ultravioleta , Replicación Viral/efectos de los fármacos
17.
J Am Acad Dermatol ; 36(5 Pt 2): 853-7, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9146567

RESUMEN

Human papillomaviruses (HPVs) are double-stranded, circular, epitheliotropic DNA viruses of which nearly 70 types have been identified. Specific HPV types exhibit a predilection to infect certain sites; however, occurrence is not unique or restricted to these sites. HPV typing may also be helpful in determining the oncogenic potential of HPV lesions. The most common HPV types, 6 and 11, are associated with benign mucosal lesions, whereas types 18, 16, 31, and 33 are thought to confer a high rate of malignant transformation. We describe a patient with both palmar verrucae and esophageal papillomatosis that proved to be HPV type 45 by polymerase chain reaction. HPV 45 has a high homology to HPV 18 and is a member of the relatively new "high-risk" mucosal HPV family in terms of cervical oncogenic potential. To our knowledge, HPV 45 has never been reported in cutaneous warts or esophageal lesions.


Asunto(s)
Neoplasias Esofágicas/virología , Boca/virología , Papiloma/virología , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/virología , Piel/virología , Infecciones Tumorales por Virus/virología , Verrugas/virología , ADN Viral/análisis , Neoplasias Esofágicas/complicaciones , Neoplasias Esofágicas/patología , Femenino , Dedos , Humanos , Persona de Mediana Edad , Papiloma/complicaciones , Papiloma/patología , Infecciones por Papillomavirus/patología , Infecciones Tumorales por Virus/patología , Verrugas/complicaciones , Verrugas/patología
18.
Am J Physiol ; 270(5 Pt 2): R963-70, 1996 May.
Artículo en Inglés | MEDLINE | ID: mdl-8928927

RESUMEN

Sleep is altered during the course of viral infection, including that in which the human immunodeficiency virus (HIV) is the etiologic agent. Alterations in the sleep of HIV-infected individuals occur early in the course of infection, prior to the onset of AIDS. The mechanisms for such alterations in sleep are not known. The HIV envelope glycoprotein 120 (gp120) induces the synthesis and secretion of cytokines that enhance [e.g., interleukin (IL)-1 and tumor necrosis factor] and suppress (e.g., IL-10 and IL-1 receptor antagonist) sleep. We used a well-defined rat model to test the hypothesis that the HIV gp120 alters sleep. Recombinant HIV-1IIIB gp120 was injected intracerebroventricularly (20- 500 ng) into rats prior to dark onset. Sleep-wake behavior was not altered after the 20-ng dose, whereas both non-rapid eye movement sleep (NREMS) and rapid eye movement sleep (REMS) were initially enhanced and subsequently suppressed after the 100-ng dose. NREMS was enhanced for 8 h after the 500-ng dose; REMS was not affected by this dose. Brain temperature was not altered by any of the gp120 doses used in this study. In addition, mRNA expression for IL-1 beta and IL-10 was induced in the hypothalamus by gp120; this brain region is crucial for the regulation of sleep. These new data support the hypothesis that altered cytokine concentrations within the central nervous system play a pivotal role in the complex alterations in sleep observed during HIV infection.


Asunto(s)
Proteína gp120 de Envoltorio del VIH/farmacología , VIH-1/química , Interleucina-10/genética , Interleucina-1/genética , ARN Mensajero/metabolismo , Sueño/efectos de los fármacos , Animales , Hipotálamo/metabolismo , Inyecciones Intraventriculares , Masculino , Ratas , Ratas Sprague-Dawley
19.
Int J Cardiol ; 53 Suppl: S47-53, 1996 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-8793593

RESUMEN

Cardiopulmonary bypass (CPB) results in a diffuse inflammatory response characterized in part by hyperstimulation of leukocytes. We have previously shown that this hyperstimulation appears to be due, in part, to an increase in the release of biological response modifiers (BRMs) such as cytokines. In the present study, we evaluated the ability of a naturally occurring immunocyte inhibitory substance, alpha-melanocyte-stimulating hormone (alpha-MSH), to prevent the hyperstimulation caused by CPB. Monocytes and granulocytes were pretreated with alpha-MSH (10(-6) M) before exposing the cells to plasma obtained from patients who had undergone CPB, as CPB plasma would stimulate native monocytes and granulocytes in a manner similar to that observed in CPB patients. Pretreatment of these cells with alpha-MSH significantly diminished the hyperstimulation induced by CPB plasma in a concentration-dependent manner. In contrast, when the cells were first or simultaneously exposed to CPB plasma and then to alpha-MSH, alpha-MSH had no effect. Furthermore, use of the specific neutral endopeptidase inhibitor, phosphoramidon, significantly increased the efficacy of alpha-MSH in inhibiting CPB-induced immunocyte activation. The data demonstrate that pretreatment of monocyte/macrophages and granulocytes with alpha-MSH effectively inhibits the immune hyperstimulation induced by CPB-plasma exposure. In addition, the data strongly suggest that preexposure to other naturally occurring immune inhibitory substances may diminish the hyperstimulation associated with CPB. The study also further confirms that this hyperstimulation may, in part, be due to BRMs released from immunocytes.


Asunto(s)
Puente Cardiopulmonar , Granulocitos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Monocitos/efectos de los fármacos , alfa-MSH/farmacología , Regulación hacia Abajo , Glicopéptidos/farmacología , Granulocitos/inmunología , Humanos , Activación de Linfocitos/efectos de los fármacos , Activación de Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Monocitos/inmunología , Neprilisina/antagonistas & inhibidores , Inhibidores de Proteasas/farmacología
20.
Crit Rev Immunol ; 16(2): 109-44, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8879941

RESUMEN

The discovery of the ability of the nervous system to communicate through "public" circuits with other systems of the body is attributed to Ernst and Berta Scharrer, who described the neurosecretory process in 1928. Indeed, the immune system has been identified as another important neuroendocrine target tissue. Opioid peptides are involved in this communication (i.e., neuroimmune) and with that of autoimmunoregulation (communication between immunocytes). The significance of opioid neuropeptide involvement with the immune system is ascertained from the presence of novel delta, mu, and kappa receptors on inflammatory cells that result in modulation of cellular activity after activation, as well as the presence of specific enzymatic degradation and regulation processes. In contrast to the relatively uniform antinociceptive action of opiate and opioid signal molecules in neural tissues, the presence of naturally occurring morphine in plasma and a novel mu3, opiate-specific receptor on inflammatory cells adds to the growing knowledge that opioid and opiate signal molecules may have antagonistic actions in select tissues. In examining various disorders (e.g., human immunodeficiency virus, substance abuse, parasitism, and the diffuse inflammatory response associated with surgery) evidence has also been found for the involvement of opiate/opioid signaling in prominent mechanisms. In addition, the presence of similar mechanisms in man and organisms 500 million years divergent in evolution bespeaks the importance of this family of signal molecules. The present review provides an overview of recent advances in the field of opiate and opioid immunoregulatory processes and speculates as to their significance in diverse biological systems.


Asunto(s)
Comunicación Celular , Sistema Inmunológico/fisiología , Narcóticos/metabolismo , Fenómenos Fisiológicos del Sistema Nervioso , Péptidos Opioides/metabolismo , Receptores Opioides/metabolismo , Animales , Humanos , Inflamación , Modelos Inmunológicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA